LINC01315

Across TCGA pan-cancer cohorts, LINC01315 RNA is linked to patient survival in 25 of 34 cancer types, making it the most broadly survival-associated LINC01315 data layer.

The strongest signal is observed in uveal melanoma (UVM), where higher LINC01315 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC01315 expression acts as an unfavorable survival marker, although some lineages such as STAD and KIRP show a favorable association.

UVM, STAD, and ACC are the cancer types where LINC01315 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	OS	Tertile	III,IV	0.291	1.000	<.001	78	view →
STAD	DFS	Quartile	II,III,IV	0.774	0.543	<.001	72	view →
ACC	DFS	Tertile	IV	0.233	0.679	.001	64	view →
KIRP	DFS	Median	All	0.902	0.552	.002	61	view →
BLCA	OS	Quartile	IV	0.784	0.498	.003	53	view →
READ	OS	Median	All	0.770	0.523	.004	44	view →
CESC	OS	Tertile	All	0.914	0.824	.011	32	view →
HNSC	DFS	Quartile	All	0.826	0.697	.013	27	view →
PAAD	OS	Tertile	All	0.637	0.392	.001	20	view →
LUAD	OS	Quartile	All	0.455	0.214	.007	17	view →
PCPG	OS	Median	All	1.000	0.728	.014	15	view →
BRCA	DFS	Tertile	III,IV	0.813	0.917	.004	15	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 25 lineages.

LINC01315–UVM (OS)

Open the UVM breakdown →